The commercial availability of Xenon 133 sourced from IRE supports Lantheus’ commitment to ensuring the medical community has continued reliable access to Xenon 133 through 2016 and beyond.

Lantheus Medical Imaging, Inc. , a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, today announced a new strategic agreement with the ...

The High Flux Reactor at Petten in the Netherlands is now producing the medical radioisotope Xenon-133. The move follows the successful collaboration between nuclear medicine company Curium and the ...

SEOUL- South Korea said on Wednesday traces of radioactive xenon gas were confirmed to be from a North Korean nuclear test earlier this month, but it was unable to conclude whether the test had bee… ...

South Korea said on Wednesday traces of radioactive xenon ... xenon-133 isotope on nine occasions, while its mobile equipment off the country's east coast detected traces of the isotope ...

Xenon is a naturally occurring, colourless gas that is used in manufacturing of some sorts of lights. But the detected xenon-133 is a radioactive isotope that does not occur naturally and which ...

But the detected xenon-133 is a radioactive isotope that does not occur naturally and which has been linked to North Korea's nuclear tests in the past.

One of the isotopes that triggered the concern, xenon-135, has a radioactive half-life of a little over nine hours; the other, xenon-133, loses half its radioactivity in just over five days.